Whole Blood Transfusion for Severe Malarial Anemia in a High Plasmodium falciparum Transmission Setting
- 19 April 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 75 (11) , 1893-1902
Abstract
Severe malaria resulting from Plasmodium falciparum infection is the leading parasitic cause of death in children worldwide, and severe malarial anemia (SMA) is the most common clinical presentation. The evidence in support of current blood transfusion guidelines for patients with SMA is limited. We conducted a retrospective cohort study of 911 hospitalized children with SMA in a holoendemic region of Zambia to examine the association of whole blood transfusion with in-hospital survival. Data were analyzed in adjusted logistic regression models using multiple imputation for missing data. The median age of patients was 24 months (interquartile range, 16–30) and overall case fatality was 16%. Blood transfusion was associated with 35% reduced odds of death in children with SMA (odds ratio, 0.65; 95% confidence interval, .52–.81; P = .0002) corresponding to a number-needed-to-treat (NNT) of 14 patients. Children with SMA complicated by thrombocytopenia were more likely to benefit from transfusion than those without thrombocytopenia (NNT = 5). Longer storage time of whole blood was negatively associated with survival and with the posttransfusion rise in the platelet count but was not associated with the posttransfusion change in hemoglobin concentration. Whole blood given to pediatric patients with SMA was associated with improved survival, mainly among those with thrombocytopenia who received whole blood stored for <4 weeks. These findings point to a potential use for incorporating thrombocytopenia into clinical decision making and management of severe malaria, which can be further assessed in prospective studies, and underline the importance of maintaining reliable blood donation networks in areas of high malaria transmission.Keywords
Funding Information
- Johns Hopkins Malaria Research Institute
- Bloomberg Philanthropies
- Division of Microbiology and Infectious Diseases
- National Institute of Allergy and Infectious Diseases
- Southern and Central Africa International Centers of Excellence for Malaria Research (U19AI089680)
- European and Developing Countries Clinical Trials Partnership
- National Institutes of Health (K23AI139343)
- Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
- Johns Hopkins University
- Burroughs Wellcome Fund
- American Society of Tropical Medicine and Hygiene
- Tropical Infectious Diseases
This publication has 46 references indexed in Scilit:
- Inter-Relationships of Cardinal Features and Outcomes of Symptomatic Pediatric Plasmodium falciparum Malaria in 1,933 Children in Kampala, UgandaThe American Journal of Tropical Medicine and Hygiene, 2013
- Predicting the Clinical Outcome of Severe Falciparum Malaria in African Children: Findings From a Large Randomized TrialClinical Infectious Diseases, 2012
- Mortality after Fluid Bolus in African Children with Severe InfectionNew England Journal of Medicine, 2011
- Beyond Clotting: The Powers of PlateletsScience, 2010
- Platelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to InfectionScience, 2009
- Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, KenyaMalaria Journal, 2008
- Blood transfusion for treating malarial anaemiaCochrane Database of Systematic Reviews, 1999
- Longitudinal evaluation of severely anemic children in KenyaAIDS, 1997
- Effect of blood transfusion on survival among children in a Kenyan hospitalThe Lancet, 1992
- Plasmodium falciparumgrowth inhibition by human plateletsin vitroParasitology, 1989